- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
uPAR Antibody recognizes urokinase plasminogen activator receptor (uPAR/CD87), a glycosylphosphatidylinositol (GPI)-anchored cell surface receptor encoded by the PLAUR gene. uPAR binds urokinase-type plasminogen activator (uPA) and localizes plasmin generation to the cell surface, promoting extracellular matrix degradation, tissue remodeling, and cellular migration. In addition to regulating proteolysis, uPAR interacts with integrins, vitronectin, and multiple signaling receptors to influence adhesion, survival, and intracellular signaling pathways. Due to its central role in cell motility and tissue remodeling, uPAR Antibody is widely used to study cancer progression, inflammatory responses, and mechanisms controlling cellular invasion.
uPAR expression is normally associated with activated immune cells, endothelial cells, fibroblasts, and tissues undergoing repair or remodeling. Increased PLAUR expression has been reported in numerous cancers, including breast, colorectal, lung, pancreatic, ovarian, and brain tumors, where it is associated with tumor invasion, epithelial-mesenchymal transition, angiogenesis, metastasis, and poor clinical outcomes. By regulating pericellular proteolysis and interactions with the tumor microenvironment, uPAR contributes to many processes required for malignant progression. As a Cell Invasion Receptor Antibody, uPAR Antibody is valuable for investigating tumor biology and mechanisms that drive cancer cell migration.
Beyond oncology, uPAR participates in immune regulation, wound healing, inflammation, and vascular biology. Expression of uPAR on monocytes, macrophages, neutrophils, and other immune populations influences leukocyte recruitment, cytokine responses, and inflammatory signaling. Soluble uPAR (suPAR), generated through receptor cleavage, has also gained attention as a biomarker associated with immune activation, chronic inflammation, kidney disease, cardiovascular disorders, and infection severity. These diverse functions highlight the importance of PLAUR in both normal physiology and disease processes.
uPAR Antibody, a Cell Invasion Receptor Antibody, provides a valuable tool for studying extracellular matrix remodeling, protease signaling, tumor invasion, and inflammatory responses. Researchers use uPAR Antibody to investigate cancer metastasis, cell migration, immune cell activation, angiogenesis, and the molecular pathways that regulate tissue remodeling and disease progression.
Explore additional Cancer Antibodies for targets involved in tumor invasion, extracellular matrix remodeling, metastasis, and cancer cell signaling.
Optimal dilution of the uPAR Antibody / Cell Invasion Receptor Antibody should be determined by the researcher.
A recombinant rat protein corresponding to amino acids L25-R261 was used as the immunogen for the uPAR antibody.
After reconstitution, the uPA Receptor antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
CD87 Antibody, PLAUR Antibody, Urokinase Receptor Antibody, Urokinase Plasminogen Activator Receptor Antibody, uPA Receptor Antibody, Cell Migration Receptor Antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.